JULIA JONES: Open Payments
NPI 1508900473 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 21 payments from 9 companies in 2025. Trend: 2023 $412 · 2024 $174 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $200 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $18 |
Products named: Kerendia, PURIFIED CORTROPHIN GEL, FARXIGA, BENLYSTA, ACTHAR, Ozempic, TAVNEOS, JARDIANCE.
Industry payments across NM — which companies pay providers there.
